N,N-dimethyl-3-[[5-(3-methyl-2-oxo-1-tetrahydropyran-4-yl-imidazo[4,5-c]quinolin-8-yl)-2-pyridyl]oxy]propan-1-amine oxide as ATM (ataxia telangiectasia mutated) kinase modulator for treating cancer

• 收藏
• 分享

专利权人:

AstraZeneca AB

发明人:

Barlaam, Bernard Christophe,Pike, Kurt Gordon

申请号：

AU2017247558

公开号：

AU2017247558A1

申请日:

2017.03.30

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The specification generally relates to the compound of Formula (I), i.e. to N,N-dimethyl-3-[[5-(3-methyl-2-oxo-l-tetrahydropyran-4-yl-imidazo[4,5-c]quinolin-8-yl)-2-pyridyl]oxy]propan-l-amine oxide as ATM (ataxia telangiectasia mutated) kinase modulator for treating cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/